title: Cholelithiasis induced in the Syrian hamster: evidence for an intramucinous nucleating process and down regulation of cholesterol 7 alpha-hydroxylase (CYP7) gene by medroxyprogesterone.
abstract: This report reviews previously published studies from our laboratory and shows some recent morphological data obtained with scanning and transmission electron microscopy regarding gallstone formation and alteration of the gallbladder epithelium in the Syrian hamster model. Both male and female hamsters were treated with female sex steroids (estradiol alone, estradiol and medroxyprogesterone, medroxyprogesterone alone) during one month. The results show that the Syrian hamster is a good model to study bile changes, gallbladder structure changes, including gallstone formation, and the regulation of cholesterol metabolism at the molecular level. Arguments in favor of this animal model are presented and, during gallstone formation, epithelial cell changes, anionic mucus secretion, and formation of gallbladder luminal deposits can be demonstrated. Recent molecular biology observations related to the effect of female sex steroids on liver cholesterol 7 alpha-hydroxylase (CYP7) gene suggest that progestin alone or primed by estrogen down regulates CYP7 transcription and activity. In addition, progesterone in cell culture systems has been shown to enhance intracellular accumulation of free cholesterol by increasing its uptake and synthesis and by decreasing its esterification by inhibiting the activity of acylcoenzyme A: cholesterol acyltransferase. Non-esterified cholesterol is free to migrate to the extracellular spaces and may contribute to nucleation within the bile. It is suggested that these effects of progesterone on cholesterol metabolism combined with the CYP7 gene down regulation, physical changes in the mucus and the hypomotility of the gallbladder and biliary ducts result in hypersaturation of cholesterol in the bile which favors gallstone formation.
authors.affiliation: Summa Health System Foundation, Akron, Ohio, 44304, USA.
authors.forename: J
authors.initials: J
authors.lastname: Gilloteaux
authors.forename: S
authors.initials: S
authors.lastname: Karkare
authors.forename: A Q
authors.initials: AQ
authors.lastname: Don
authors.forename: R C
authors.initials: RC
authors.lastname: Sexton
mesh_terms: D000214:Acyl Coenzyme A / Q000378:metabolism; D000818:Animals; D001646:Bile / Q000737:chemistry; D002769:Cholelithiasis / Q000235:genetics / Q000378:metabolism* / Q000648:ultrastructure; D002784:Cholesterol / Q000378:metabolism; D002790:Cholesterol 7-alpha-Hydroxylase / Q000235:genetics* / Q000378:metabolism*; D006224:Cricetinae; D015536:Down-Regulation; D004577:Electron Probe Microanalysis; D004848:Epithelium / Q000378:metabolism / Q000648:ultrastructure; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D005704:Gallbladder / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D008055:Lipids / Q000032:analysis / Q000097:blood; D008297:Male; D008525:Medroxyprogesterone / Q000494:pharmacology*; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning; D008861:Microsomes / Q000378:metabolism; D009077:Mucins / Q000378:metabolism; D009093:Mucus / Q000378:metabolism; D045167:Progesterone Congeners / Q000494:pharmacology*; D011372:Progestins / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism; D011987:Receptors, Steroid; D002785:Sterol O-Acyltransferase / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects
chemical_list: D000214:Acyl Coenzyme A; D008055:Lipids; D009077:Mucins; D045167:Progesterone Congeners; D011372:Progestins; D012333:RNA, Messenger; D011987:Receptors, Steroid; D004958:Estradiol; D002784:Cholesterol; D002790:Cholesterol 7-alpha-Hydroxylase; D002785:Sterol O-Acyltransferase; D008525:Medroxyprogesterone